Polaris Venture Capital logo

Polaris Venture Capital

Asia, Tel Aviv, Israel, Tel Aviv

Description

PVC is committed to building successful enterprises through value-added partnerships with promising technology companies.

Investor Profile

Polaris Venture Capital has backed more than 18 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 12 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series Unknown, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Israel, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Software.

Stage Focus

  • Series B (28%)
  • Series Unknown (17%)
  • Seed (11%)
  • Series A (11%)
  • Series D (6%)
  • Series C (6%)
  • Series E (6%)
  • Series G (6%)
  • Private Equity (6%)
  • Pre Seed (6%)

Country Focus

  • United States (89%)
  • Israel (6%)
  • Germany (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Pharmaceutical
  • Therapeutics
  • Audio
  • Consumer Electronics
  • Wireless
  • Medical Device
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Polaris Venture Capital frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
SG
North America, Massachusetts, United States, Stoneham
Co-Investments: 1
Advent Venture Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Baxter International
North America, Illinois, United States, Deerfield
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Venture Capital Fund of New England
North America, Massachusetts, United States, Wellesley
Co-Investments: 3
Ascension Ventures
North America, Missouri, United States, Clarkton
Co-Investments: 1
AV
North America, Florida, United States, Miami
Co-Investments: 1

Which angels does Polaris Venture Capital often collaborate with?

Dan Burgess
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Polaris Venture Capital?

Freckle

Cambridge, Massachusetts, United States

Freckle offers a data enrichment and research platform for non-technical users.

Data ManagementSoftware
Pre SeedDec 2, 2024
Amount Raised: $1,900,000
Seraxis

Germantown, Maryland, United States

Seraxis is a privately owned biotechnology company.

BiotechnologyHealth Care
Series CFeb 9, 2021
Amount Raised: $40,000,000
NakedPoppy

San Francisco, California, United States

NakedPoppy is a clean beauty company that curates better-for-you beauty brands and tailors them to you.

BeautyCosmeticsHealth CareWomen's
SeedMar 27, 2019
Amount Raised: $4,087,068
Lyra Therapeutics

Watertown, Massachusetts, United States

Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.

BiotechnologyHealth CarePharmaceuticalTherapeuticsWellness
Series BSep 26, 2018
Amount Raised: $29,500,000
Respicardia

Minnetonka, Minnesota, United States

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

Health CareMedical DeviceTherapeutics
Series UnknownDec 19, 2017
Amount Raised: $58,500,000
Cardlytics

Atlanta, Georgia, United States

Cardlytics uses purchase-based intelligence to make marketing more relevant and measurable.

AdvertisingBankingFinancial ServicesMobile
Series GMay 18, 2017
Amount Raised: $11,940,331
aTyr Pharma

San Diego, California, United States

aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series EMar 31, 2015
Amount Raised: $76,000,000
Ocular Therapeutix

Bedford, Massachusetts, United States

Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.

BiotechnologyHealth CareMedical Device
Series DJun 10, 2013
Amount Raised: $23,800,000
Avitide

Lebanon, New Hampshire, United States

Avitide develops affinity purification solutions for biopharmaceutical companies.

BiotechnologyHealth CareLife Science
Series AMar 4, 2013
Amount Raised: $1,440,000
Avila Therapeutics

Waltham, Massachusetts, United States

Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.

BiotechnologyHealth CareMedical
Series BJul 27, 2009
Amount Raised: $30,000,000

Find More Investors Like Polaris Venture Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Polaris Venture Capital | Pipeseed